Go Pro
→ BlackRock and Vanguard already own THIS (From Monument Traders Alliance) (Ad)tc pixel Free EYPT Stock Alerts

Eyepoint Pharmaceuticals (EYPT) Short Interest Ratio & Short Volume

Eyepoint Pharmaceuticals logo
$4.25 +0.02 (+0.47%)
Closing price 04:00 PM Eastern
Extended Trading
$4.26 +0.00 (+0.12%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Eyepoint Pharmaceuticals Short Interest Overview

As of August 31, 2026, Eyepoint Pharmaceuticals (EYPT) had a short interest of 18.11 million shares sold short, representing 22.14% of the public float. This marks a -1.72% decrease in short interest since the prior report. The short interest ratio (days to cover) is 1.7, meaning it would take 1.7 days of the average trading volume of 7.16 million shares to cover all short positions.

Current Short Interest
18,110,761 shares
Previous Short Interest
18,426,891 shares
Change Vs. Previous Month
-1.72%
Dollar Volume Sold Short
$81.50 million
Short Interest Ratio
1.7 Days to Cover
Last Record Date
August 31, 2026
Outstanding Shares
86,210,000 shares
Short Percent of Float
22.14%
Today's Trading Volume
2,531,416 shares
Average Trading Volume
7,157,467 shares
Today's Volume Vs. Average
35%
Short Selling Eyepoint Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Eyepoint Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

EYPT Short Interest Over Time

EYPT Days to Cover Over Time

EYPT Percentage of Float Shorted Over Time

Eyepoint Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/202618,110,761 shares $81.50 million -1.7%22.1%1.72 $4.50
8/14/202618,426,891 shares $271.80 million +2.3%22.5%9.1 $14.75
7/31/202618,015,023 shares $220.68 million +9.7%22.0%12.35 $12.25
7/15/202616,425,378 shares $227.49 million +8.7%20.7%10.33 $13.85
6/30/202615,114,767 shares $215.76 million +0.3%19.0%9.61 $14.28
6/15/202615,077,303 shares $182.13 million -0.1%19.0%13.84 $12.08
5/29/202615,097,978 shares $205.03 million +6.7%19.0%15.09 $13.58
5/15/202614,152,914 shares $174.79 million -0.2%17.7%16.88 $12.35
4/30/202614,186,473 shares $187.26 million +3.9%17.7%16.59 $13.20
4/15/202613,659,042 shares $199.83 million +2.0%17.2%15.93 $14.63
3/31/202613,385,952 shares $172.54 million +7.3%16.8%14.06 $12.89
3/13/202612,478,689 shares $164.72 million +14.8%15.7%7.52 $13.20
2/27/202610,868,767 shares $190.86 million +14.1%13.6%4.51 $17.56
2/13/20269,529,005 shares $123.31 million +10.3%12.0%7.86 $12.94
1/30/20268,638,845 shares $116.80 million +4.4%10.9%9.51 $13.52
1/15/20268,272,026 shares $131.03 million -4.2%10.5%8.54 $15.84
12/31/20258,632,273 shares $157.71 million +18.1%10.9%6.61 $18.27
12/15/20257,308,090 shares $119.85 million -7.3%9.2%6.63 $16.40
11/28/20257,881,028 shares $116.88 million -8.7%10.0%7.08 $14.83
11/14/20258,632,226 shares $99.96 million +14.2%13.1%5.88 $11.58
10/31/20257,558,136 shares $98.94 million -7.0%11.5%5.85 $13.09
10/15/20258,130,000 shares $95.36 million +1.6%12.3%8.1 $11.73
9/30/20258,000,000 shares $113.92 million -10.0%N/A9.6 $14.24
9/15/20258,890,000 shares $119.21 million +5.2%N/A11.2 $13.41
8/31/20258,450,000 shares $97.77 million +9.9%12.8%11.5 $11.57
8/15/20257,690,000 shares $85.28 million +11.3%N/A9.8 $11.09
7/31/20256,910,000 shares $67.86 million +2.8%10.5%8.9 $9.82
7/15/20256,720,000 shares $66.12 million -3.0%N/A8.4 $9.84
6/30/20256,930,000 shares $65.21 million +2.8%10.5%8.3 $9.41
6/15/20256,740,000 shares $60.86 million -6.0%10.3%8.1 $9.03
5/31/20257,170,000 shares $51.70 million -0.6%11.0%8.6 $7.21
5/15/20257,210,000 shares $41.24 million -28.4%11.1%9.2 $5.72
4/30/202510,070,000 shares $68.68 million -14.8%N/A12.4 $6.82
4/15/202511,820,000 shares $67.02 million +8.1%18.2%14 $5.67
3/31/202510,930,000 shares $59.24 million +0.9%16.8%12.8 $5.42
3/15/202510,830,000 shares $70.61 million +0.9%16.7%12.6 $6.52
2/28/202510,730,000 shares $67.28 million -3.3%16.5%12.4 $6.27
2/15/202511,090,000 shares $72.09 million +3.5%17.1%12.3 $6.50
1/31/202510,720,000 shares $82.01 million +1.3%N/A11.9 $7.65
1/15/202510,580,000 shares $81.36 million +2.3%N/A11 $7.69
The trade I’ve been waiting for since 2011 (Ad)

Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this supercycle - and says that may be conservative. Billionaire Pierre Lassonde has argued for $19,000. Former CIA advisor Jim Rickards targets $27,000 based on a federal revaluation of the gold supply. But the bigger opportunity may not be gold itself. A 'backdoor' gold-linked asset has historically multiplied gold's move by 10x or more - returning 846%, 1,668%, 1,847%, and 1,915% in the last supercycle.tc pixel

Watch the free video briefing and learn the No. 1 trade to leverage rising gold
12/31/202410,340,000 shares $77.03 million +9.9%N/A10.8 $7.45
12/15/20249,410,000 shares $70.20 million +1.7%N/A10.3 $7.46
11/30/20249,250,000 shares $81.86 million -6.4%N/A10.8 $8.85
11/15/20249,880,000 shares $90.60 million +2.1%N/A12.2 $9.17
10/31/20249,680,000 shares $113.84 million +5.6%N/A13.1 $11.76
10/15/20249,170,000 shares $90.60 million +2.7%N/A15.9 $9.88
9/30/20248,930,000 shares $71.35 million -1.9%N/A13.8 $7.99
9/15/20249,100,000 shares $82.81 million -0.1%N/A12.8 $9.10
8/31/20249,110,000 shares $81.53 million -3.9%N/A12.6 $8.95
8/15/20249,480,000 shares $77.74 million -0.7%N/A11.6 $8.20
7/31/20249,550,000 shares $94.35 million -5.3%N/A10.7 $9.88
7/15/202410,080,000 shares $106.24 million +4.7%N/A8.8 $10.54
6/30/20249,630,000 shares $83.78 million +7.2%N/A8.5 $8.70
6/15/20248,980,000 shares $84.23 million +16.0%N/A8.2 $9.38
5/31/20247,740,000 shares $82.90 million -4.8%N/A6.7 $10.71
5/15/20248,130,000 shares $105.20 million +23.2%N/A7 $12.94
4/30/20246,600,000 shares $116.16 million +0.9%N/A5.6 $17.60
4/15/20246,540,000 shares $139.17 million -4.5%N/A6.7 $21.28
3/31/20246,850,000 shares $141.59 million +4.1%N/A7.1 $20.67
3/15/20246,580,000 shares $141.34 million +15.0%N/A6.4 $21.48
2/29/20245,720,000 shares $155.64 million +20.4%N/A4.5 $27.21
2/15/20244,750,000 shares $138.13 million -7.6%N/A2.9 $29.08
1/31/20245,140,000 shares $138.42 million -1.2%N/A3.3 $26.93
1/15/20245,200,000 shares $118.35 million -2.4%N/A3.5 $22.76
12/31/20235,330,000 shares $123.18 million +12.2%N/A3.9 $23.11
12/15/20234,750,000 shares $92.86 million -32.2%N/A3.6 $19.55
11/30/20237,010,000 shares $43.81 million +28.9%25.0%5.9 $6.25
11/15/20235,440,000 shares $36.39 million +1.7%19.4%10.3 $6.69
10/31/20235,350,000 shares $32.21 million +9.0%19.2%10.3 $6.02
10/15/20234,910,000 shares $39.77 million -29.3%17.6%9.3 $8.10
9/30/20236,940,000 shares $55.45 million +12.3%25.1%11.6 $7.99
9/15/20236,180,000 shares $64.77 million +9.2%22.3%10.2 $10.48
8/31/20235,660,000 shares $56.09 million +12.1%20.6%9.5 $9.91
8/15/20235,050,000 shares $71.66 million +3.7%18.8%8.9 $14.19
7/31/20234,870,000 shares $60.88 million +1.9%N/A9.3 $12.50
7/15/20234,780,000 shares $52.44 million -7.7%N/A4.9 $10.97
6/30/20235,180,000 shares $45.07 million +7.5%N/A5.6 $8.70
6/15/20234,820,000 shares $32.73 million +13.2%18.4%5.3 $6.79
5/31/20234,260,000 shares $25.77 million +5.2%16.2%4.8 $6.05
5/15/20234,050,000 shares $24.30 million +11.3%15.4%4.7 $6.00
4/30/20233,640,000 shares $22.86 million -0.3%14.1%4.4 $6.28
4/15/20233,650,000 shares $15.80 million +9.3%14.2%5.3 $4.33
3/31/20233,340,000 shares $9.82 million +19.7%13.0%11 $2.94
3/15/20232,790,000 shares $6.67 million +34.8%10.9%10 $2.39
2/28/20232,070,000 shares $6.91 million No Change8.1%8.1 $3.34
2/15/20232,070,000 shares $7.66 million -4.2%8.1%8.5 $3.70
1/31/20232,160,000 shares $10.07 million +6.9%8.6%9.3 $4.66
1/15/20232,020,000 shares $10.18 million +13.5%8.0%9.4 $5.04
12/30/20221,780,000 shares $6.23 million +6.0%7.1%12.3 $3.50
12/15/20221,680,000 shares $4.50 million -2.9%6.7%11.6 $2.68
Why major institutions are piling into this digital asset now (Ad)

BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.tc pixel

Get the name, the ticker, and exactly how to buy it
11/30/20221,730,000 shares $5.54 million -3.4%6.9%13.6 $3.20
11/15/20221,790,000 shares $7.91 million -9.1%7.1%14.1 $4.42
10/31/20221,970,000 shares $10.64 million -1.5%N/A16.1 $5.40
10/15/20222,000,000 shares $11.20 million -1.5%7.7%14.3 $5.60
9/30/20222,030,000 shares $16.06 million -0.5%7.8%12.5 $7.91
9/15/20222,040,000 shares $16.30 million +0.5%7.9%12.7 $7.99
8/31/20222,030,000 shares $20.30 million +1.5%7.8%12.7 $10.00
8/15/20222,000,000 shares $22.24 million -8.3%7.7%12.8 $11.12
7/31/20222,180,000 shares $19.90 million +7.4%8.3%13.8 $9.13
7/15/20222,030,000 shares $20.12 million +1.0%7.8%14.4 $9.91
6/30/20222,010,000 shares $15.82 million +2.0%7.7%16.8 $7.87
6/15/20221,970,000 shares $15.62 million -5.3%7.5%16.7 $7.93
5/31/20222,080,000 shares $20.07 million -3.3%8.0%16 $9.65
5/15/20222,150,000 shares $21.26 million -1.4%8.2%14.1 $9.89
4/30/20222,180,000 shares $24.63 million +0.5%8.3%13.4 $11.30
4/15/20222,170,000 shares $27.54 million +0.5%8.3%11.9 $12.69
3/31/20222,160,000 shares $26.24 million +4.9%8.3%9.6 $12.15
3/15/20222,060,000 shares $24.82 million +3.0%7.9%7.9 $12.05
2/28/20222,000,000 shares $19.90 million +3.6%7.7%7.2 $9.95
2/15/20221,930,000 shares $19.59 million -2.5%7.4%6.6 $10.15
1/31/20221,980,000 shares $18.55 million -8.3%7.6%2.4 $9.37
1/15/20222,160,000 shares $21.45 million +11.3%N/A2.7 $9.93
12/31/20211,940,000 shares $23.75 million +0.5%7.4%2.5 $12.24
12/15/20211,930,000 shares $28.27 million -3.5%7.4%2.6 $14.65
11/30/20212,000,000 shares $31.60 million +98.0%8.1%2.9 $15.80
11/15/20211,010,000 shares $14.44 million -34.0%4.2%1.5 $14.30
10/29/20211,530,000 shares $17.55 million +10.9%7.3%11 $11.47
10/15/20211,380,000 shares $15.79 million +0.7%6.6%12.1 $11.44
9/30/20211,370,000 shares $14.28 million -3.5%6.5%11.3 $10.42
9/15/20211,420,000 shares $14.31 million +2.9%6.8%8.4 $10.08

EYPT Short Interest - Frequently Asked Questions

Short interest is the volume of Eyepoint Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 18,110,761 shares of EYPT short. 22.14% of Eyepoint Pharmaceuticals' shares are currently sold short. Learn More on Eyepoint Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EYPT shares currently have a short interest ratio of 1.7. Learn More on Eyepoint Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.14% of Eyepoint Pharmaceuticals' floating shares are currently sold short.

Eyepoint Pharmaceuticals saw a drop in short interest during the month of August. As of August 31st, there was short interest totaling 18,110,761 shares, a drop of 1.7% from the previous total of 18,426,891 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

22.14% of Eyepoint Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceuticals" compare to Eyepoint Pharmaceuticals: LB Pharmaceuticals Inc (17.37%), Innoviva, Inc. (9.80%), Xeris Biopharma Holdings, Inc. (4.61%), Phibro Animal Health Corporation (5.97%), Alto Neuroscience, Inc. (11.02%), Harrow, Inc. (20.74%), Seaport Therapeutics, Inc. (5.89%), Cronos Group Inc. (0.95%), Pacira BioSciences, Inc. (19.64%), Spyglass Pharma, Inc. (3.28%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($62.68 billion), Invesco QQQ ($47.06 billion), iShares Russell 2000 ETF ($23.54 billion), SPDR S&P Biotech ETF ($12.10 billion), Nebius Group N.V. ($9.34 billion), Western Digital Corporation ($8.96 billion), Financial Select Sector SPDR Fund ($8.16 billion), iShares 20+ Year Treasury Bond ETF ($7.98 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.52 billion), and VanEck Semiconductor ETF ($7.39 billion). View all of the most shorted stocks.

Short selling EYPT is an investing strategy that aims to generate trading profit from Eyepoint Pharmaceuticals as its price is falling. EYPT shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Eyepoint Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EYPT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EYPT, twice per month. The most recent reporting period available is August, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like EYPT:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:EYPT is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners
The national debt just passed $39 trillion
The U.S. national debt just topped $39 trillion, up nearly $3 trillion in a single year and on pace to hit $40...
US Gold Bureau | Sponsoredtc pixel
“This is the Perfect Tech Stock”
Jeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...
Brownstone Research | Sponsoredtc pixel
BlackRock and Vanguard already own THIS
Institutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 ...
Monument Traders Alliance | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
Gold majors have a big problem
Newmont spent 15 billion dollars acquiring Newcrest in 2023, the largest deal in gold mining history. Yet prod...
Golden Portfolio | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
My next big call (under $1)
My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called ...
Crypto 101 Media | Sponsoredtc pixel